Purchase comes weeks after Swedish mycoprotein specialist filed for bankruptcy.
Belgium-based Naplasol agreed to pay an undisclosed price to acquire Mycorena AB, a pioneer in mycoprotein development that offers fungi fermentation technology used to create alternative protein products.
Naplasol plans to continue production of Mycorena’s flagship Promyc mycoprotein at the Swedish firm’s industrial facility in Bree, Belgium, in a deal that will…